Characterization of in vitro activity and predictive biomarkers of the novel p21-activated kinase 4 (PAK4) inhibitor, PF-3758309, in colorectal cancer cell lines

被引：0
|
作者：
Kulikowski, Gillian N.
Pitts, Todd M.
Tan, Aik Choon
Tentler, John J.
Britt, Blair C.
Britt, Byron W.
Murray, Brion W.
Carley, William
Smeal, Tod
Guo, Chuangxing
Eckhardt, S. Gail
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-B169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B169
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor
    Ryu, Byung Jun
    Kim, Sunmin
    Min, Bora
    Kim, Keon Young
    Lee, Jin Soo
    Park, Whui Jung
    Lee, Hyuk
    Kim, Seong Hwan
    Park, SangYoun
    CANCER LETTERS, 2014, 349 (01) : 45 - 50
  • [32] Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4) (vol 5, 1257, 2022)
    Ha, Byung Hak
    Yigit, Sezin
    Natarajan, Nalini
    Morse, Elizabeth M.
    Calderwood, David A.
    Boggon, Titus J.
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [33] ROLE OF P21-ACTIVATED KINASE, PAK4, IN ACTIVATION OF NUMEROUS IMPORTANT CELLULAR SIGNALING CASCADES IN PANCREATIC ACINAR CELLS
    Ramos, Irene
    Lee, Lingaku
    Mantey, Samuel A.
    Iordanskaia, Tatiana
    Jensen, Robert T.
    GASTROENTEROLOGY, 2020, 158 (06) : S508 - S508
  • [34] HBW-008-A, a Novel, Potent, Selective, Safe and Bioavailable p21-Activated Kinase 4 (PAK4) Inhibitor, is an Efficacious Adjuvant Agent for PD-1 Therapy in Mice
    Lee, Ning
    Li, Yingfu
    Liu, Guanfeng
    Yang, Mao
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [35] p21 activated kinase 4 (pak4) as a novel therapeutic target for non-hodgkin's lymphoma
    Azmi, Asfar S.
    Aboukameel, Amro
    Muqbil, Irfana
    Li, Yiwei
    Senapedis, William
    Baloglu, Erkan
    Landesman, Yosef
    Kauffman, Michael
    Shacham, Sharon
    Al-Katib, Ayad
    Mohammad, Ramzi M.
    CANCER RESEARCH, 2017, 77
  • [36] PRESENCE OF THE P21-ACTIVATED KINASE, PAK4, IN PANCREATIC ACINAR CELLS AND ITS ACTIVATION BY NUMEROUS GASTROINTESTINAL HORMONES AND GROWTH FACTORS
    Ramos, Irene
    Nuche-Berenguer, Bernardo
    Moreno, Paola
    Mantey, Samuel A.
    Iordanskaia, Tatiana
    Jensen, Robert T.
    GASTROENTEROLOGY, 2017, 152 (05) : S902 - S902
  • [37] P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration
    Song, Bao
    Wang, Wei
    Zheng, Yan
    Yang, Jianshu
    Xu, Zhongfa
    JOURNAL OF SURGICAL RESEARCH, 2015, 196 (01) : 130 - 135
  • [38] The role of p21 activated kinase (PAK) in human colorectal cancer cell lines and resistance to cetuximab
    Servetto, A.
    D'Amato, V.
    Rosa, R.
    Di Mauro, C.
    Ciciola, P.
    Orsini, R. C.
    Marciano, R.
    de Placido, S.
    Bianco, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [39] Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors
    Hao, Chenzhou
    Zhao, Fan
    Song, Hongyan
    Guo, Jing
    Li, Xiaodong
    Jiang, Xiaolin
    Huan, Ran
    Song, Shuai
    Zhang, Qiaoling
    Wang, Ruifeng
    Wang, Kai
    Pang, Yu
    Liu, Tongchao
    Lu, Tianqi
    Huang, Wanxu
    Wang, Jian
    Lin, Bin
    He, Zhonggui
    Li, Haitao
    Li, Feng
    Zhao, Dongmei
    Cheng, Maosheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (01) : 265 - 285
  • [40] The P21-activated kinase PAK4 is implicated in fatty-acid potentiation of insulin secretion downstream of free fatty acid receptor 1
    Bergeron, Valerie
    Ghislain, Julien
    Poitout, Vincent
    ISLETS, 2016, 8 (06) : 157 - 164
12345